Halozyme Therapeutics Inc (HALO) earnings · P/E 36, rev $1.40B
These earnings events as JSON? API free 100/dayHalozyme Therapeutics Inc (HALO) is a biotechnology company listed on US.
This HALO earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported HALO revenue for 2025-12-31 was $1.40B. Net income was $316.9M. Revenue was up 37.6% from 2024-12-31 to 2025-12-31. HALO currently screens at market cap $7.10B and trailing P/E 35.7.
When the next HALO 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 37.6% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full HALO research stays on the stock page; the tape stays on the quote page.
HALO earnings FAQ
What are HALO's latest revenue and net income?
Latest cached Halozyme Therapeutics Inc (HALO) revenue for Dec 31, 2025 was $1.40B. Net income was $316.9M. Statements: https://lician.com/financials/halo
What is HALO's latest diluted EPS?
Latest cached Halozyme Therapeutics Inc (HALO) diluted EPS for Dec 31, 2025 was $2.56.
What period does the latest HALO earnings print cover?
The latest cached Halozyme Therapeutics Inc (HALO) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did HALO revenue change from the prior cached period?
Cached Halozyme Therapeutics Inc (HALO) revenue was up 37.6% from $1.02B (Dec 31, 2024) to $1.40B (Dec 31, 2025). Statements: https://lician.com/financials/halo
What is HALO's P/E ratio?
Halozyme Therapeutics Inc (HALO) trailing P/E is 35.7 on the latest cached fundamentals snapshot.
Where are HALO earnings listed?
Cached earnings facts for Halozyme Therapeutics Inc (HALO) are listed at https://lician.com/earnings/halo. Statements: https://lician.com/financials/halo
Not investment advice.